ARK Investment Management LLC Sells 875,514 Shares of Repare Therapeutics Inc. (NASDAQ:RPTX)

Key Points

• ARK Investment Management LLC reduced its stake in Repare Therapeutics by 43.8%, selling 875,514 shares and owning 1,124,483 shares after the transaction.
• JPMorgan Chase & Co. significantly increased its holdings in Repare Therapeutics by over 2 million percent during the fourth quarter, now owning 85,802 shares valued at $112,000.
• Repare Therapeutics currently trades at $1.56 with a market cap of approximately $66.91 million and has a 12-month price range between $0.89 and $4.22.

ARK Investment Management LLC decreased its stake in Repare Therapeutics Inc. (NASDAQ:RPTX - Free Report) by 43.8% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,124,483 shares of the company's stock after selling 875,514 shares during the quarter. ARK Investment Management LLC owned 2.62% of Repare Therapeutics worth $1,109,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently modified their holdings of the company. Millennium Management LLC increased its holdings in shares of Repare Therapeutics by 65.5% in the fourth quarter. Millennium Management LLC now owns 170,959 shares of the company's stock worth $224,000 after acquiring an additional 67,638 shares in the last quarter. Stifel Financial Corp increased its holdings in shares of Repare Therapeutics by 73.1% in the fourth quarter. Stifel Financial Corp now owns 89,500 shares of the company's stock worth $117,000 after acquiring an additional 37,800 shares in the last quarter. Tower Research Capital LLC TRC increased its holdings in shares of Repare Therapeutics by 204.7% in the fourth quarter. Tower Research Capital LLC TRC now owns 34,423 shares of the company's stock worth $45,000 after acquiring an additional 23,127 shares in the last quarter. Lynx1 Capital Management LP bought a new stake in shares of Repare Therapeutics in the fourth quarter worth about $104,000. Finally, JPMorgan Chase & Co. grew its holdings in shares of Repare Therapeutics by 2,144,950.0% during the fourth quarter. JPMorgan Chase & Co. now owns 85,802 shares of the company's stock worth $112,000 after buying an additional 85,798 shares in the last quarter. 85.09% of the stock is currently owned by institutional investors.

Repare Therapeutics Stock Up 0.3%

Shares of NASDAQ:RPTX traded up $0.01 during mid-day trading on Wednesday, reaching $1.54. 13,646 shares of the stock were exchanged, compared to its average volume of 331,400. The company has a market cap of $65.84 million, a P/E ratio of -0.51 and a beta of 0.84. Repare Therapeutics Inc. has a one year low of $0.89 and a one year high of $4.07. The stock's 50 day simple moving average is $1.45 and its 200-day simple moving average is $1.28.

Repare Therapeutics Profile

Repare Therapeutics Inc, a clinical-stage precision oncology company, engages in the discovery and development of therapeutics by using its synthetic lethality approach in Canada and the United States. It uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform, to discover, validate, and build a pipeline of SL-based therapeutics that focuses on genomic instability, including DNA damage repair.